Page 76 - Read Online

Torres et al. J Cancer Metastasis Treat 2018;4:4 I http://dx.doi.org/10.20517/2394-4722.2017.49 Page 23 of 25

185. Maciag P, Radulovic S, Rothman J. The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a phase I safety study of
Lm-LLO-E7 in patients with advanced carcinoma of the cervix. Vaccine 2009;27:3975-83.
186. Theys J, Pennington O, Dubois L, Anlezark G, Vaughan T, Mengesha A, Landuyt W, Anné J, Burke PJ, Dûrre P, Wouters BG, Minton
NP, Lambin P. Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo. Br J
Cancer 2006;95:1212-9.
187. Fabricius EM, Schneeweiss U, Schau HP, Schmidt W, Benedix A. Quantitative investigations into the elimination of in vitro-obtained
spores of the non-pathogenic Clostridium butyricum strain CNRZ 528, and their persistence in organs of different species following
intravenous spore administration. Res Microbiol 1993;144:741-53.
188. Nuyts S, Van Mellaert L, Theys J, Landuyt W, Bosmans E, Anné J, Lambin P. Radio-responsive recA promoter significantly increases
TNFα production in recombinant clostridia after 2 Gy irradiation. Gene Ther 2001;8:1197-1201.
189. Barbé S, Mellaert L, Theys J, Geukens N, Lammertyn E, Lambin P, Anné J. Secretory production of biologically active rat interleukin-2
by Clostridium acetobutylicum DSM792 as a tool for anti-tumor treatment. FEMS Microbiol Lett 2005;246:67-73.
190. Bermudes D, Low K, Ittensohn M, Le T, Platt J, Sodi S, Amoss M, Ash O, Carmichael E, Chakraborty A, Fischer J, Lin SL, Luo X,
Miller SI, Zheng L, King I, Pawelek JM, Bermudes D. Lipid a mutant Salmonella with suppressed virulence and TNFalpha induction
retain tumor-targeting in vivo. Nat Biotechnol 1999;17:37-41.
191. Clairmont C, Lee KC, Pike J, Ittensohn M, Low KB, Pawelek J, Bermudes D, Brecher SM, Margitich D, Turnier J, Li Z, Luo X, King
I, Zheng LM. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella
typhimurium. J Infect Dis 2000;181:1996-2002.
192. Forbes N. Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer 2010;10:785-94.
193. Aghi M, Hochberg F, Breakefield X. Prodrug activation enzymes in cancer gene therapy. J Gene Med 2000;2:148-64.
194. Nagakura C, Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Bouvet M, Hoffman RM. Efficacy of a
genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. Anticancer Res 2009;29:1873-8.
195. Hiroshima Y, Zhao M, Zhang Y, Maawy A, Hassanein M, Uehara F, Miwa S, Yano S, Momiyama M, Suetsugu A, Chishima T, Tanaka
K, Bouvet M, Endo I, Hoffman RM. Comparison of efficacy of Salmonella typhimuriumA1-R and chemotherapy on stem-like and non-
stem human pancreatic cancer cells. Cell Cycle 2013;12:2774-80.
196. Momiyama M, Zhao M, Kimura H, Tran B, Chishima T, Bouvet M, Endo I, Hoffman RM. Inhibition and eradication of human glioma
with tumor-targetingSalmonella typhimuriumin an orthotopic nude-mouse model. Cell Cycle 2012;11:628-32.
197. Murakami T, Hiroshima Y, Zhao M, Zhang Y, Chishima T, Tanaka K, Bouvet M, Endo I, Hoffman RM. Therapeutic efficacy of tumor-
targeting Salmonella typhimurium A1-R on human colorectal cancer liver metastasis in orthotopic nude-mouse models. Oncotarget
2015;6:31368-77.
198. Matsumoto Y, Miwa S, Zhang Y, Hiroshima Y, Yano S, Uehara F, Yamamoto M, Toneri M, Bouvet M, Matsubara H, Hoffman RM, Zhao
M. Efficacy of tumor-targeting Salmonella typhimurium A1-R on nude mouse models of metastatic and disseminated human ovarian
cancer. J Cell Biochem 2014;115:1996-2003.
199. Zhang Y, Zhang N, Zhao M, Hoffman RM. Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and
VNP20009 on the Lewis lung carcinoma in nude mice. Oncotarget 2015;6:14625-31.
200. Yano S, Zhang Y, Miwa S, Tome Y, Hiroshima Y, Uehara F, Yamamoto M, Suetsugu A, Kishimoto H, Tazawa H, Zhao M, Bouvet M,
Fujiwara T, Hoffman RM. Spatial-temporal FUCCI imaging of each cell in a tumor demonstrates locational dependence of cell cycle
dynamics and chemoresponsiveness. Cell Cycle 2014;13:2110-9.
201. Yano S, Zhang Y, Zhao M, Hiroshima Y, Miwa S, Uehara F, Kishimoto H, Tazawa H, Bouvet M, Fujiwara T, Hoffman RM. Tumor-
targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycles as visualized by FUCCI imaging and become sensitive
to chemotherapy. Cell Cycle 2014;13:2958-3963.
202. Jia H, Li Y, Zhao T, Li X, Hu J, Yin D, Guo B, Kopecko DJ, Zhao X, Zhang L, Xu DQ. Antitumor effects of Stat3-siRNA and endostatin
combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma. Cancer Immunol Immunother
2012;61:1977-87.
203. Park SY, Groisman EA. Signal-specific temporal response by the SalmonellaPhoP/PhoQ regulatory system. Mol Microbiol 2013;91:135-44.
204. Hohmann EL, Oletta CA, Killeen KP, Miller SI. PhoP/PhoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single dose
typhoid fever vaccine in volunteers. J Infect Dis 1996;173:1408-14.
205. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009;9:798-809.
206. Nam S, Buettner R, Turkson J, Kim D, Cheng JQ, Muehlbeyer S, Hippe F, Vatter S, Merz KH, Eisenbrand G, Jove R. Indirubin
derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc Natl Acad Sci U S A 2005;102:5998-6003.
207. Wake MS, Watson CJ. STAT3 the oncogene-still eluding therapy? FEBS J 2015;282:2600-11.
208. Chen Y, Liu X, Jin C, Zhou YC, Navab R, Jakobsen KR, Chen XQ, Li J, Li TT, Luo L, Wang XC. An orally administered DNA vaccine
targeting vascular endothelial growth factor receptor-3 inhibits lung carcinoma growth. Tumour Biol 2015;37:2395-404.
209. Xu X, Hegazy WA, Guo L, Gao X, Courtney AN, Kurbanov S, Liu D, Tian G, Manuel ER, Diamond DJ, Hensel M, Metelitsa LS.
Effective cancer vaccine platform based on attenuated Salmonella and a Type III secretion system. Cancer Res 2014;74:6260-70.
210. Weiskirch LM, Pan ZK, Paterson Y. The tumor recall response of antitumor immunity primed by a live, recombinant listeria
monocytogenes vaccine comprises multiple effector mechanisms. Clin Immunol 2001;98:346-57.
211. Jahangir A, Chandra D, Quispe-Tintaya W, Singh M, Selvanesan BC, Gravekamp C. Immunotherapy with Listeria reduces metastatic
breast cancer in young and old mice through different mechanisms. Onco Immunology 2017;6:e1342025.